|
Volumn 22, Issue 12, 2004, Pages 1521-1522
|
Knocking the SOCS1 off dendritic cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 1BETA;
INTERLEUKIN 4;
INTERLEUKIN 6;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
PROSTAGLANDIN E2;
SMALL INTERFERING RNA;
SUPPRESSOR OF CYTOKINE SIGNALING 1;
TUMOR NECROSIS FACTOR ALPHA;
ANTIGEN PRESENTATION;
CONTROLLED STUDY;
DENDRITIC CELL;
DRUG EFFICACY;
EX VIVO STUDY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOSTIMULATION;
IMMUNOTHERAPY;
INHIBITION KINETICS;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN FUNCTION;
SHORT SURVEY;
ANIMALS;
ANTIGEN PRESENTATION;
CARRIER PROTEINS;
CELL DIFFERENTIATION;
CELL LINE, TUMOR;
DENDRITIC CELLS;
GENE SILENCING;
IMMUNOTHERAPY, ADOPTIVE;
MELANOMA;
MICE;
MICE, INBRED C57BL;
REPRESSOR PROTEINS;
SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;
|
EID: 11144317795
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt1204-1521 Document Type: Short Survey |
Times cited : (8)
|
References (10)
|